Science, Passion and Results
FREE ROAD MAP TO FDA WHITE-PAPER
The ITC Transporter White Paper provides detailed guidance for transporter mediated DDI studies for the seven transporters recommended in the March 17, 2010 FDA Advisory Committee vote. Get the White Paper and a Road Map Summary to help navigate it.
QUESTIONS?
Speak with one of our DMPK specialists about your needs to understand how we can help you and the results you can expect.
CONTACT US:
888-OPTIVIA (888-678-4842)
About Optivia
Located in the San Francisco Bay Area, Optivia Biotechnology was founded by a team of seasoned entreprenuers and industry veterans who have started and led successful biotechnology and biopharmaceutical companies. As industry insiders, we understand the issues and challenges of drug development, and are strongly committed to lead and utilize innovations in transporter biology for better, faster and cheaper drug development.
Optivia offers a suite of transporter assay services and products to assist drug development companies discover and design better drugs with improved therapeutic responses and safety profiles. Our clients and collaborators include pharmaceutical and biotechnology companies, research institutions and government agencies.
Located in the San Francisco Bay Area, Optivia Biotechnology was founded by a team of seasoned entreprenuers and industry veterans who have started and led successful biotechnology and biopharmaceutical companies. As industry insiders, we understand the issues and challenges of drug development, and are strongly committed to lead and utilize innovations in transporter biology for better, faster and cheaper drug development.
Optivia offers a suite of transporter assay services and products to assist drug development companies discover and design better drugs with improved therapeutic responses and safety profiles. Our clients and collaborators include pharmaceutical and biotechnology companies, research institutions and government agencies.